Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	21.49B
Revenue (ttm)	9.42B
Net Income (ttm)	1.15B
Shares Out	1.49B
EPS (ttm)	0.79
PE Ratio	18.26
Forward PE	16.41
Dividend	0.25 (1.73%)
Ex-Dividend Date	Jul 10, 2024

Volume	15,003,634
Average Volume	16,478,786
Open	14.50
Previous Close	14.42
Day's Range	14.36 - 14.63
52-Week Range	13.49 - 21.55
Beta	0.52
RSI	45.70
Earnings Date	Apr 30, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 8,221
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2023, SHA:600521's revenue was 8.31 billion, an increase of 0.52% compared to the previous year's 8.27 billion. Earnings were 830.47 million, a decrease of -28.88%.